ROCK-solid Inhibition in Glaucoma Therapy

0.75 CME
$0 FEE
ROCK Solid Inhibition


Provider Statement

This continuing medical education activity is provided by Vindico Medical Education.

Support Statement

This activity is supported by an educational grant from Aerie Pharmaceuticals, Inc.

Target Audience

The intended audience for the activity is comprehensive ophthalmologists and other health care professionals involved in the treatment of patients with glaucoma.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Review the mechanisms of action of new and emerging intraocular pressure-lowering agents targeting the rho-kinase pathway.
  • Evaluate evidence-based literature concerning the safety and efficacy of novel rho-kinase inhibitors in clinical practice.

Activity Chair

John R. Samples, MD
Clinical Professor
Elson S. Floyd College of Medicine
Washington State University
Spokane, WA
Western Glaucoma Foundation
Olympia, WA


Thomas W. Samuelson, MD
Attending Surgeon
Minnesota Eye Consultants, P.A.
Adjunct Professor of Ophthalmology
University of Minnesota
Minneapolis, MN

Janet B. Serle, MD
Professor of Ophthalmology
Glaucoma Fellowship Director
Icahn School of Medicine at Mount Sinai
New York, NY


Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP


Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, March 18, 2019 through March 17, 2020.

How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, view content, and complete the CME posttest and evaluation. Provide only one (1) answer for each question. A satisfactory score is defined as answering 2 of the 3 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.


In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.

Activity Chair and Faculty report the following relationship(s)

John R. Samples, MD
Royalty: Allergan, Kugler, Refocus Group, Springer
Intellectual Property/Patent: Allergan, ClearPath, EyeGenetix, Refocus Group
Consulting Fee: Alcon, ALeyeGN, Novartis
Speakers Bureau: Aerie, Alcon, Novartis
Contracted Research: National Eye Institute, NIH

Thomas W. Samuelson, MD
Consulting Fee: Abbott Medical Optics, AcuMems, Aerie, Akorn, Alcon, Allergan/Equinox, AqueSys/Allergan, Bausch + Lomb, BELKIN Laser, Endo Optiks, Glaukos, Imprimis, Ivantis, MicroOptx, New World Medical, Omeros, Santen, Shire, SLACK, TearClear
Ownership Interest: AqueSys/Allergan, BELKIN Laser, Allergan/Equinox, Glaukos, Ivantis, TearClear

Janet B. Serle, MD
Speakers Bureau: Aerie, Bausch + Lomb
Contracted Research: Allergan, Ocular Therapeutix
Ownership Interest: Aerie
Advisory Board: Aerie, Allergan, Bausch + Lomb

Reviewer reports the following relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2019 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at